文献速递复苏、休克与脓毒症心脑血管急症重症综合管理与镇静镇痛

C23肽在大鼠心脏骤停复苏模型中的保护作用

THE PROTECTIVE EFFECT OF C23 IN A RAT MODEL OF CARDIAC ARREST AND RESUSCITATION.
PubMed 文献 · Shock · 2023-03-20
一句话结论大鼠心脏骤停复苏模型中,C23肽(8 mg/kg)于自主循环恢复时腹腔注射可降低全身炎症、减少海马神经元凋亡并改善存活率与神经预后。

该研究在大鼠心脏骤停/心肺复苏模型中,于自主循环恢复(ROSC)开始时腹腔注射C23肽(8 mg/kg)或生理盐水。结果显示,ROSC后24小时血清和脑组织中CIRP、TNF-α、IL-6、IL-1β表达显著升高(P<0.05);C23治疗可显著降低血清中TNF-α、IL-6、IL-1β表达(P<0.05),并降低皮层和海马中TLR4、TNF-α、IL-6、IL-1β表达,抑制CIRP与TLR4共定位(P<0.05),减少海马神经元凋亡(P<0.05),改善存活率和神经预后(P<0.05)。作者认为C23可减轻全身炎症,有潜力开发为心脏骤停后综合征的候选疗法。

要点

  • 成年雄性SD大鼠经历5分钟心脏骤停后复苏,ROSC开始时腹腔注射C23肽8 mg/kg或生理盐水。
  • ROSC后24小时血清和脑组织中CIRP、TNF-α、IL-6、IL-1β表达显著升高(P<0.05)。
  • C23治疗显著降低血清TNF-α、IL-6、IL-1β表达(P<0.05),并降低皮层和海马TLR4、TNF-α、IL-6、IL-1β表达、抑制CIRP与TLR4共定位(P<0.05)。
  • C23治疗减少海马神经元凋亡(P<0.05),并改善大鼠存活率与神经预后(P<0.05)。
  • 作者认为C23可减轻全身炎症,有潜力开发为心脏骤停后综合征的候选疗法。

适用人群与场景

  • 成年雄性SD大鼠,实验组经历5分钟心脏骤停后复苏。

处置流程与药物剂量

  • C23肽(8 mg/kg)或生理盐水在自主循环恢复(ROSC)开始时腹腔注射。

研究设计与关键结果

  • 研究类型:大鼠心脏骤停/心肺复苏模型实验。
  • 干预与对照:C23肽(8 mg/kg)腹腔注射 vs 生理盐水,均在ROSC开始时给药。
  • ROSC后24小时血清和脑组织中CIRP、TNF-α、IL-6、IL-1β表达显著升高(P<0.05)。
  • C23治疗显著降低血清TNF-α、IL-6、IL-1β表达(P<0.05)。
  • C23治疗降低皮层和海马TLR4、TNF-α、IL-6、IL-1β表达,抑制CIRP与TLR4共定位(P<0.05)。
  • C23治疗减少海马神经元凋亡(P<0.05)。
  • C23组大鼠存活率和神经预后改善(P<0.05)。

证据类型、等级与局限

  • 证据类型:动物实验(大鼠心脏骤停/心肺复苏模型)。
  • 局限:原文未报告局限性

对床旁实践的改变

  • 作者认为C23可减轻全身炎症,有潜力开发为心脏骤停后综合征的候选疗法。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

Background : Systemic inflammation acts as a contributor to neurologic deficits after cardiac arrest (CA) and cardiopulmonary resuscitation (CPR). Extracellular cold-inducible RNA-binding, protein (CIRP) has been demonstrated to be responsible in part for the inflammation through binding to toll-like receptor 4 (TLR4) after cerebral ischemia. The short peptide C23 derived from CIRP has a high affinity for TLR4, we hypothesize that C23 reduces systemic inflammation after CA/CPR by blocking the binding of CIRP to TLR4. Methods : Adult male SD rats in experimental groups were subjected to 5 min of CA followed by resuscitation. C23 peptide (8 mg/kg) or normal saline was injected intraperitoneally at the beginning of the return of spontaneous circulation (ROSC). Results : The expressions of CIRP, TNF-α, IL-6, and IL-1β in serum and brain tissues were significantly increased at 24 h after ROSC ( P < 0.05). C23 treatment could markedly decrease the expressions of TNF-α, IL-6, and IL-1β in serum ( P < 0.05). Besides, it can decrease the expressions of TLR4, TNF-α, IL-6, and IL-1β in the cortex and hippocampus and inhibit the colocalization of CIRP and TLR4 ( P < 0.05). In addition, C23 treatment can reduce the apoptosis of hippocampus neurons ( P < 0.05). Finally, the rats in the C23 group have improved survival rate and neurological prognosis ( P < 0.05). Conclusions: These findings suggest that C23 can reduce systemic inflammation and it has the potential to be developed into a possible therapy for post-CA syndrome.

来源:Shock,查看原文。版权归原作者所有。

参考来源

  1. Gao Y, Liu H, Zhou J, et al. THE PROTECTIVE EFFECT OF C23 IN A RAT MODEL OF CARDIAC ARREST AND RESUSCITATION. Shock. 2023. PMID: 36930651. doi:10.1097/SHK.0000000000002113

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。